SEC Form 4 · accession 0000899243-15-005348
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E. Hughes
Officer — Chief Executive Officer · Director
Period of report
Sep 23, 2015
Accepted (ET)
Sep 24, 2015 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 23, 2015 | M | 10,500 | $0.75 | A | 11,320 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F2 | $0.75 | Sep 23, 2015 | M | 10,500 | D | — | Dec 15, 2018 | Common Stock | 10,500 | 53,928 | D |
Explanation of responses
- F1Includes 428 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan (the "Plan") on June 30, 2015 and 392 shares acquired under the Plan on December 31, 2014.
- F2Fully vested.
- F3On April 6, 2015, the Reporting Person transferred 64,429 shares under this option pursuant to a court decree. The Reporting Person no longer reports as beneficially owned such transferred securities.